Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (151-160 of 216) with videos related to

Pageof 22
Sort By:
Blood|May 22, 2009
A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cellsHideto Matsui, Masaru Shibata, Brian Brown, et al.
Journal of Thrombosis and Haemostasis : JTH|July 3, 2022
Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding scoreMichelle Lavin, Pamela Christopherson, Julie Grabell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 24, 2020
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round TableGlenn F Pierce, K John Pasi, Donna Coffin, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2023
A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?Leonard A Valentino, Margareth C Ozelo, Roland W Herzog, et al.
American Journal of Hematology|March 2, 2017
Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia AVeerle Labarque, Vanitha Perinparajah, Vanessa Bouskill, et al.
Blood|February 25, 2011
Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse modelsCynthia M Pruss, Mia Golder, Andrea Bryant, et al.
Haematologica|April 21, 2018
Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanismsMaria T Georgescu, Paul C Moorehead, Alice S van Velzen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 13, 2020
Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular diseaseSuzan de Boer, Mackenzie Bowman, Colleen Notley, et al.
Journal of Thrombosis and Haemostasis : JTH|December 1, 2023
The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence changePamela A Christopherson, Nathalie Tijet, Sandra L Haberichter, et al.
Blood|March 27, 2013
The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levelsNatalia Rydz, Laura L Swystun, Colleen Notley, et al.
Pageof 22

Showing results (151-160 of 216) with videos related to

Sort By:
Pageof 22
Blood|May 22, 2009
A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cellsHideto Matsui, Masaru Shibata, Brian Brown, et al.
Journal of Thrombosis and Haemostasis : JTH|July 3, 2022
Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding scoreMichelle Lavin, Pamela Christopherson, Julie Grabell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 24, 2020
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round TableGlenn F Pierce, K John Pasi, Donna Coffin, et al.
Journal of Thrombosis and Haemostasis : JTH|May 24, 2023
A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?Leonard A Valentino, Margareth C Ozelo, Roland W Herzog, et al.
American Journal of Hematology|March 2, 2017
Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia AVeerle Labarque, Vanitha Perinparajah, Vanessa Bouskill, et al.
Blood|February 25, 2011
Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse modelsCynthia M Pruss, Mia Golder, Andrea Bryant, et al.
Haematologica|April 21, 2018
Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanismsMaria T Georgescu, Paul C Moorehead, Alice S van Velzen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 13, 2020
Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular diseaseSuzan de Boer, Mackenzie Bowman, Colleen Notley, et al.
Journal of Thrombosis and Haemostasis : JTH|December 1, 2023
The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence changePamela A Christopherson, Nathalie Tijet, Sandra L Haberichter, et al.
Blood|March 27, 2013
The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levelsNatalia Rydz, Laura L Swystun, Colleen Notley, et al.
Pageof 22